drugset / Trial / NCT05800834

Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds

NCT05800834

Phase 2 Unknown 106 enrolled Brazilian National Cancer Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to compare in compare pain reduction in patients with malignant wounds using morphine gel or lidocaine gel. The main question to be answered is: • Does morphine gel offer better pain control in malignant wounds when compared to lidocaine gel? Participants will answer a questionnaire where they report a note for pain at the site of the malignant wound and then the dressing will be performed by a nurse from the research team. The patient and the nurse do not know which product is being used. At the end of the dressing, the patient answers a new questionnaire. This process will be carried out for 3 days. The researchers will compare the intervention group (morphine gel) and the control group (lidocaine gel) and verify if there is a difference in pain reduction between the two products.

Timeline

Start
2023-09-12
Primary completion
2024-03
Completion
2024-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 %
Subject Morphine Other / unclassified 10 mg Topical